Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.36EUR
541.43 MEUR
3.35 BEUR
190.28 M
About Incyte Corporation
Sector
CEO
Herve Hoppenot
Headquarters
Wilmington
Website
Employees (FY)
2.52 K
Founded
1991
FIGI
BBG00KH5J166
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.
An aggregate view of professional's ratings.
Curated watchlists where 4INCY is featured.
Frequently Asked Questions
The current price of 4INCY is 58.54 EUR — it has decreased by −1.18% in the past 24 hours. Watch INCYTE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EUROTLX exchange INCYTE stocks are traded under the ticker 4INCY.
4INCY stock has risen by 2.09% compared to the previous week, the month change is a 0.79% rise, over the last year INCYTE has showed a 4.95% increase.
We've gathered analysts' opinions on INCYTE future price: according to them, 4INCY price has a max estimate of 82.75 EUR and a min estimate of 43.18 EUR. Watch 4INCY chart and read a more detailed INCYTE stock forecast: see what analysts think of INCYTE and suggest that you do with its stocks.
4INCY reached its all-time high on Oct 27, 2017 with the price of 99.82 EUR, and its all-time low was 47.42 EUR and was reached on Apr 25, 2024. View more price dynamics on 4INCY chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4INCY stock is 1.20% volatile and has beta coefficient of 0.97. Track INCYTE stock price on the chart and check out the list of the most volatile stocks — is INCYTE there?
Today INCYTE has the market capitalization of 11.53 B, it has increased by 2.44% over the last week.
Yes, you can track INCYTE financials in yearly and quarterly reports right on TradingView.
INCYTE is going to release the next earnings report on Oct 29, 2024. Keep track of upcoming events with our Earnings Calendar.
4INCY earnings for the last quarter are −1.70 EUR per share, whereas the estimation was 0.70 EUR resulting in a −343.09% surprise. The estimated earnings for the next quarter are 1.12 EUR per share. See more details about INCYTE earnings.
INCYTE revenue for the last quarter amounts to 974.46 M EUR, despite the estimated figure of 947.46 M EUR. In the next quarter, revenue is expected to reach 965.45 M EUR.
4INCY net income for the last quarter is −415.08 M EUR, while the quarter before that showed 157.13 M EUR of net income which accounts for −364.16% change. Track more INCYTE financial stats to get the full picture.
No, 4INCY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 21, 2024, the company has 2.52 K employees. See our rating of the largest employees — is INCYTE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INCYTE EBITDA is 112.86 M EUR, and current EBITDA margin is 19.87%. See more stats in INCYTE financial statements.
Like other stocks, 4INCY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INCYTE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INCYTE technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INCYTE stock shows the neutral signal. See more of INCYTE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.